Montage Resources Corp
Change company Symbol lookup
Select an option...
MR Montage Resources Corp
AMAG AMAG Pharmaceuticals Inc
HCI Hci Group Inc
PSF Cohen & Steers Select Preferred and Income Fund
PJT PJT Partners Inc
ALK Alaska Air Group Inc
RS Reliance Steel & Aluminum Co
HFWA Heritage Financial Corp
MET MetLife Inc
KALU Kaiser Aluminum Corp
Go

Energy : Oil, Gas & Consumable Fuels | Small Cap Value
Company profile

Montage Resources Corp, formerly Eclipse Resources Corp, is an independent exploration and production company. The Company is engaged in the acquisition and development of oil and natural gas properties in the Appalachian Basin. It is the operator of the Utica Core Area and its Marcellus Project Area. The Ordovician-aged Utica Shale is an unconventional reservoir consisting of organic-rich black shale, with production occurring at vertical depths between 6,000 and 10,000 feet. The Marcellus Shale consists of organic-rich black shale, with production occurring at vertical depths between 5,000 and 8,000 feet. As of December 31, 2016, it had approximately 92,000 net acres in the Utica Shale in Eastern Ohio within the Utica Core Area. As of December 31, 2016, the Company had assembled an acreage position approximating 199,000 net acres in Eastern Ohio.

Closing Price
$5.78
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
5.96
Day's Low
5.67
Volume
(Above Average)
Volume:
499,161

10-day average volume:
430,428
499,161

Immunology Market to Rise Impressively at 8.1% CAGR and Touch USD 143,833.2 Million by 2026; High Prevalence of Immunological Disorders to Boost the Market, says Fortune Business Insights

9:59 am ET October 8, 2020 (Globe Newswire) Print

The Global Immunology Market is likely to expand in the coming years driven by the high prevalence of immunological disorders, resulting from environmental factors. According to a report published by Fortune Business Insights, titled "Immunology Market: Global Market Analysis, Insights and Forecast, 2019-2026," the market was valued at US$ 77,365.4 Mn in 2018. Fortune Business Insights has predicted that the market will reach US$ 143,833.2 Mn by 2026 and will exhibit a CAGR of 8.1%.

Highlights of the Report:

-- Analysis of the impact of Covid-19 that the market would face in the near future.

-- In-depth analysis of the growth drivers and obstacles.

-- Profile of all the companies operating in the market.

-- Elaborate data about the dominating region.

-- Competitive landscape consisting of mergers & acquisitions, investments, partnerships, new product launches, opening of new facilities, and new contracts.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/immunology-market-100657

Recent Product Approvals by Regulatory Agencies to Bode Well for the Overall Market

The spate of recent regulatory approvals for the immunology products is anticipated to contribute to the overall positive growth of the market. For instance, the recent regulatory approval and the subsequent launch of TREMFYA (Guselkumab) by Janssen Global Services, LLC (Johnson & Johnson), is expected to lead to better outcome for the patients.

TREMFYA (Guselkumab) was launched for the treatment of moderate to severe plaque psoriasis, a seriously debilitating immunological disorder. TREMFYA is the only biologic approved for the treatment of moderate to severe plaque psoriasis, that selectively blocks the interleukin (IL)-23, leading to a vast improvement in the symptoms of the patient.

Apart from being one of the emerging drugs of the immunology market, Fortune Business Insights predicts that Janssen Global Services, LLC (Johnson & Johnson) latest product offering will have a positive impact on the global immunology market in the forthcoming years.

The global economy is in absolute turmoil because of the COVID-19 pandemic outbreak. Some industries remain largely unaffected by the outbreak, some are thriving, but most are in doldrums. Although the healthcare industry is flourishing, certain markets within the industry are experiencing staggered growth. Wading through these troubled times is a difficult task and Fortune Business Insights(TM) aims at equipping your business with the most comprehensive market insights, collated and analyzed by our expert and experienced research team.

Click here to get the short-term and long-term impact of COVID-19 on this market.

Please visit: https://www.fortunebusinessinsights.com/industry-reports/immunology-market-100657

AbbVie Gains FDA Approval of SKYRIZI; Product to Witness High Demand in No Time

The global immunology market has gained impetus from the availability of several regulatory approved drugs. The approval of new drugs and the trends of improvements in clinical efficiencies will bode well for the global immunology market. In 2019, AbbVie received approval from the Food and Drug Administration (FDA) for the usage of 'SKYRIZI'.

The drug was aimed at the treatment of moderate to severe plaque psoriasis. This drug was inclined towards the treatment of adults diagnosed with psoriasis and have been recommended for or undergoing therapy. The drug is likely to gain huge popularity among healthcare professionals and its high clinical efficacy will fuel the demand in the coming years.

Besides product launches and drug approvals, Fortune Business Insights assesses several other factors that have made significant growth contributions to the global immunology market. Companies are encouraged by the growing usage approvals by regulatory authorities across the world. Several company mergers and acquisitions have also accounted for growth of the global immunology market.

Quick Buy - Immunology Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/100657

List of Global Immunology Market Players:

-- AbbVie Inc.

-- Janssen Global Services, LLC (Johnson & Johnson)

-- F. Hoffmann-La Roche Ltd

-- Amgen Inc.

-- Pfizer Inc.

-- Novartis AG

-- Astellas

-- Bristol-Myers Squibb Company

-- Merck Sharp & Dohme Corp.

-- UCB SA

-- ALLERGAN

-- Other Prominent Players

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/immunology-market-100657

Global Immunology Market Segmentation:

By Drug Class

? Monoclonal antibody (mAb)

? Fusion Proteins

? Immunosuppressants

? Polyclonal antibody (pAb)

? Others

By Disease Indication

? Rheumatoid Arthritis

? Psoriatic Arthritis

? Plaque Psoriasis

? Ankylosing Spondylitis

? Inflammatory Bowel Disease

? Prophylaxis of Organ Rejection

? Others

By Distribution Channel

? Hospital Pharmacies

? Retail Pharmacies

? Online Pharmacies

? Others

By Geography

? North America (U.S., and Canada)

? Europe (Germany, U.K., France, Italy, Spain, Scandinavia, and Rest of Europe)

? Asia Pacific (China, India, Japan, Australia, South East Asia, and Rest of Asia Pacific)

? Latin America (Brazil, Mexico, and the Rest of Latin America)

? Middle East & Africa (GCC, South Africa, and Rest of Middle East & Africa)

Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/immunology-market-100657

Have a Look at Related Reports:

Ophthalmic Surgical Devices Market Share & Industry Analysis, By Surgery Type (Cataract Surgery Devices, Vitreoretinal Surgery Devices, Refractive Error Surgery Devices, Glaucoma Surgery Devices), By End-user (Hospitals, Ophthalmic Clinics, Others), and Regional Forecast, 2019-2026

Adult Diapers Market Share & Industry Analysis, By Product Type (Underwear & Briefs, Pads & Guards, and Drip Collectors & Bed Protectors), By Gender (Male and Female) By Distribution Channel (Institutional Sales, Retail Stores, and Online Channels) and Regional Forecast, 2019-2026

Influenza Medication Market Share & Industry Analysis, By Treatment (Baloxavir marboxil, Oseltamivir phosphate, Others), By Influenza Type (Influenza A, Influenza B), By Route of Administration (Oral, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026

Hormonal Contraceptives Market Share & Industry Analysis, By Product (Pills, Injectable, Vaginal Rings, Intrauterine Devices, Implants, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Channel, Public Channel & NGOs, and Others) and Regional Forecast, 2019-2026

Mobility Scooter Market Share & Industry Analysis, By Wheels (3 Wheels, 4 Wheels, and Others) End-user (Personal User and Institutional User) and Regional Forecast, 2019-2026

About Us:

Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights(TM) Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune - 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Fortune Business Insights(TM)

LinkedIn | Twitter | Blogs

Press Release: https://www.fortunebusinessinsights.com/press-release/immunology-market-9140

https://ml.globenewswire.com/media/05408ba1-26b1-4fdd-8f48-1af4df373348/small/fbi-logo-tm-png.png

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.